EFFECT OF AVACOPAN, A SELECTIVE C5A RECEPTOR INHIBITOR, ON KIDNEY FUNCTION IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
11:00am - 11:00am EDT - March 20, 2022
11:00am - 11:00am EDT - March 20, 2022
Author(s):
- David R. W. Jayne, Department of Medicine, University of Cambridge
- Peter A. Merkel, Division of Rheumatology, University of Pennsylvania
- Annette Bruchfeld, Linköping University, Karolinska Institutet
- Duvuru Geetha, Johns Hopkins
- Alexandre Karras, Hôpital Européen Georges-Pompidou
- John Niles, Massachusetts General Hospital
- Pirow Bekker, ChemoCentryx, Inc.
| Display Label | Action |
|---|---|
| RNL22P8 - EFFECT OF AVACOPAN, A SELECTIVE C5A RECEPTOR INHIBITOR, ON KIDNEY FUNCTION IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS | Download MP3 |